For citations:
Zyryanov S.K., Frolov M.Yu., Dyakov I.N. Clinical economic assessment of the use of pazopanib in the therapy of disseminated kidney cancer. Cancer Urology. 2016;12(1):106-114. https://doi.org/10.17650/1726-9776-2016-12-1-106-114
Zyryanov S.K., Frolov M.Yu., Dyakov I.N. Clinical economic assessment of the use of pazopanib in the therapy of disseminated kidney cancer. Cancer Urology. 2016;12(1):106-114. https://doi.org/10.17650/1726-9776-2016-12-1-106-114